| چکیده انگلیسی مقاله |
Autism is a neurodevelopmental disorder that is recognized by stereotypic and repetitive behaviors after 2 years of old. Dysregulation of the immune system, especially inflammation which is mostly regulated by IL-6, imposes a deficit in CNS development. Along with this crucial biomarker, researchers have proposed BCL-2, micro RNA-23a-3p (miR-23a-3p), miR-181b-5p as other probable biomarkers involved in inflammation and apoptosis. The aim of the study was to evaluate the alteration in the expression of these biomarkers in a group of autism spectrum disorder (ASD) children. Peripheral blood mononuclear cells (PBMCs) were obtained from 37 autistic patients. After RNA extraction with precipitation method, the Syber green qReal-time Polymerase Chain Reaction (PCR) was performed in order to evaluate the possible alteration in the expression of IL-6, BCL-2, miR-181b-5p, and miR-23a-3p. The results were compared with healthy controls. IL-6 was significantly upregulated in ASD patients (p=0.003). On the other hand, miR-23a was upregulated and BCL-2 downregulated in ASD patients but the changes were not significant. In initial evaluations, expression changes of miR-181b-5p were not statistically significant. However, when Patients were divided into two groups of upregulated and downregulated, re-evaluation showed that both up- (p=0.005) and down-regulation (p=0.004) (i.e. changes regardless of the direction) of miR-181b were significant in autistic children. IL-6 and miR-181b-5p can have proper diagnostic values and are reliable biomarkers with high sensitivity and specificity. On the other hand, PBMC can be utilized for such studies and also evaluation of patients' condition instead of brain tissue as it is less accessible. |
| نویسندگان مقاله |
| Hossein Atwan
Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran AND Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
| Mohammad-Ali Assarehzadegan
Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran AND Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
| Mehdi Shekarabi
Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran AND Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
| Seyed Mohammad Jazayeri
Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran AND Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran
| Shahram Barfi
Department of Virology, School of Public Health, International Campus, Tehran University of Medical Sciences Tehran, Iran
| Raheleh Shokouhi Shoormasti
Immunology, Asthma, and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran
| Narges Chimeh
Behara Rehabilitation Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| Hamid Reza Pouretemad
Department of Psychological Medicine, Clinical Neurophysiology Section, Institute of Psychiatry, Shahid Beheshti University, Tehran, Iran
| Behnoosh Tayebi
Department of Regenerative Medicine, Royan Institute for Stem Cell Biology and Technology, Tehran, Iran
|